Edition:
United Kingdom

Applied Genetic Technologies Corp (AGTC.OQ)

AGTC.OQ on NASDAQ Stock Exchange Global Market

4.85USD
24 Apr 2018
Change (% chg)

$-0.25 (-4.90%)
Prev Close
$5.10
Open
$5.10
Day's High
$5.15
Day's Low
$4.85
Volume
9,694
Avg. Vol
19,571
52-wk High
$6.03
52-wk Low
$3.28

Latest Key Developments (Source: Significant Developments)

Applied Genetic posts qtrly ‍net loss of $0.08​ per share
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Applied Genetic Technologies Corp :Quarterly revenue $10.3 million versus $11.8 million.Company expects total cash, cash equivalents, and investments as of june 30, 2018 to be between $85 and $100 million​.Qtrly ‍net loss per share $0.08​.  Full Article

Applied Genetic Technologies announces orphan medicinal product designation in European Union for gene therapy
Tuesday, 7 Jun 2016 

Applied Genetic Technologies Corp :Announces orphan medicinal product designation in European Union for gene therapy to treat x-linked retinitis pigmentosa.  Full Article

AGTC announces results for the quarter ended March 31
Monday, 9 May 2016 

Applied Genetic Technologies Corp : Agtc announces financial results for the quarter ended march 31, 2016 .Quarterly revenue $12 million versus $284,000.  Full Article

BRIEF-AGTC Doses First Patient In Phase 1/2 Clinical Study Of Gene Therapy For Treatment Of X-Linked Retinitis Pigmentosa

* AGTC DOSES FIRST PATIENT IN PHASE 1/2 CLINICAL STUDY OF GENE THERAPY FOR TREATMENT OF X-LINKED RETINITIS PIGMENTOSA Source text for Eikon: Further company coverage: